Drybench Patent.
Patent and exclusivity dates from July to December 2031 for NDAs, as FDA's Orange Book lists them
Each patent and exclusivity date from July to December 2031 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.
FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.
- Orange Book captured
- 14 October 2026
Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.
This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.
Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.
NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book
Listed dates, 2031January to June 2031
Listed patent expiry (312)
1 Jul 2031 · NDA 202331 · AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
US 9,387,249, use patent
patent.txt lines 3,067, 3,070- Flags
- use code U-3
- Product numbers
- 001, 002
3 Jul 2031 · NDA 214373 · BEXAGLIFLOZIN
US 10,533,032, use patent
patent.txt line 15,727- Flags
- use code U-2214
- Product numbers
- 001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,685- Flags
- product use code U-1698
- Product numbers
- 001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,686- Flags
- product use code U-3160
- Product numbers
- 001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,687- Flags
- product use code U-3171
- Product numbers
- 001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,688- Flags
- product use code U-4415
- Product numbers
- 001
4 Jul 2031 · NDA 205596 · POSACONAZOLE
US 9,023,790, product and use patent
patent.txt line 5,689- Flags
- product use code U-4416
- Product numbers
- 001
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt lines 11,506, 11,529- Flags
- use code U-2336
- Product numbers
- 001, 002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,530- Flags
- use code U-2802
- Product numbers
- 002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,531- Flags
- use code U-2803
- Product numbers
- 002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,532- Flags
- use code U-3738
- Product numbers
- 002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,533- Flags
- use code U-4051
- Product numbers
- 002
4 Jul 2031 · NDA 210496 · ENCORAFENIB
US 9,314,464, use patent
patent.txt line 11,534- Flags
- use code U-4440
- Product numbers
- 002
4 Jul 2031 · NDA 210498 · BINIMETINIB
US 9,314,464, use patent
patent.txt line 11,553- Flags
- use code U-2332
- Product numbers
- 001
4 Jul 2031 · NDA 210498 · BINIMETINIB
US 9,314,464, use patent
patent.txt line 11,554- Flags
- use code U-3737
- Product numbers
- 001
8 Jul 2031 · NDA 216472 · LATANOPROST
US 8,637,054, product and use patent
patent.txt line 18,818- Flags
- product use code U-446
- Product numbers
- 001
10 Jul 2031 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR
US RE50453, substance and product patent
patent.txt lines 11,446, 11,478- Flags
- substance product
- Product numbers
- 001, 002
10 Jul 2031 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US RE50453, substance and product patent
patent.txt lines 13,730, 13,794- Flags
- substance product
- Product numbers
- 001, 002
10 Jul 2031 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US RE50453, substance and product patent
patent.txt lines 20,134, 20,209- Flags
- substance product
- Product numbers
- 001, 002
10 Jul 2031 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US RE50453, substance and product patent
patent.txt lines 21,226, 21,277- Flags
- substance product
- Product numbers
- 001, 002
11 Jul 2031 · NDA 207202 · ARIPIPRAZOLE
US 11,229,378, product patent
patent.txt lines 7,064, 7,091, 7,118, 7,145, 7,172, 7,199- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006
15 Jul 2031 · NDA 211911 · BIMATOPROST
US 8,629,185, substance and product patent
patent.txt line 13,226- Flags
- substance product
- Product numbers
- 001
15 Jul 2031 · NDA 215352 · PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE
US 10,839,960, use patent
patent.txt line 16,803- Flags
- use code U-3685
- Product numbers
- 001
15 Jul 2031 · NDA 215352 · PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE
US 11,398,306, use patent
patent.txt line 16,804- Flags
- use code U-3685
- Product numbers
- 001
15 Jul 2031 · NDA 215352 · PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE
US 11,839,487, use patent
patent.txt line 16,805- Flags
- use code U-3685
- Product numbers
- 001
17 Jul 2031 · NDA 207921 · BECLOMETHASONE DIPROPIONATE
US 8,931,476, product patent
patent.txt lines 7,454, 7,471- Flags
- product
- Product numbers
- 001, 002
18 Jul 2031 · NDA 208051 · NERATINIB MALEATE
US 8,669,273, use patent
patent.txt line 8,021- Flags
- use code U-3047
- Product numbers
- 001
18 Jul 2031 · NDA 208692 · CABOZANTINIB S-MALATE
US 10,034,873, use patent
patent.txt lines 9,177, 9,197, 9,217- Flags
- use code U-2488
- Product numbers
- 001, 002, 003
18 Jul 2031 · NDA 208692 · CABOZANTINIB S-MALATE
US 10,039,757, use patent
patent.txt lines 9,178, 9,198, 9,218- Flags
- use code U-1480
- Product numbers
- 001, 002, 003
18 Jul 2031 · NDA 209360 · ANGIOTENSIN II ACETATE
US 9,572,856, use patent
patent.txt lines 10,190, 10,220- Flags
- use code U-2221
- Product numbers
- 001, 003
19 Jul 2031 · NDA 210884 · SUMATRIPTAN
US 9,211,282, product and use patent
patent.txt line 12,379- Flags
- product use code U-1719
- Product numbers
- 001
19 Jul 2031 · NDA 211527 · TRIFAROTENE
US 7,807,708, substance and product patent
patent.txt line 12,879- Flags
- substance product
- Product numbers
- 001
21 Jul 2031 · NDA 021539 · ACETYLCYSTEINE
US 9,327,028, use patent
patent.txt line 630- Flags
- use code U-1839
- Product numbers
- 001
29 Jul 2031 · NDA 209128 · SUFENTANIL CITRATE
US 8,945,592, product patent
patent.txt line 9,803- Flags
- product
- Product numbers
- 001
31 Jul 2031 · NDA 209863 · TESTOSTERONE ENANTHATE
US 10,279,131, product patent
patent.txt lines 10,917, 10,940, 10,963- Flags
- product
- Product numbers
- 001, 002, 003
1 Aug 2031 · NDA 207988 · LESINURAD
US 9,216,179, use patent
patent.txt line 7,930- Flags
- use code U-1806
- Product numbers
- 001
1 Aug 2031 · NDA 209203 · ALLOPURINOL; LESINURAD
US 9,216,179, use patent
patent.txt lines 9,865, 9,873- Flags
- use code U-2104
- Product numbers
- 001, 002
2 Aug 2031 · NDA 214518 · TECOVIRIMAT
US 10,576,165, product patent
patent.txt line 15,862- Flags
- product
- Product numbers
- 001
2 Aug 2031 · NDA 214518 · TECOVIRIMAT
US 9,233,097, product patent
patent.txt line 15,865- Flags
- product
- Product numbers
- 001
2 Aug 2031 · NDA 214518 · TECOVIRIMAT
US 9,907,859, use patent
patent.txt line 15,866- Flags
- use code U-3377
- Product numbers
- 001
4 Aug 2031 · NDA 206162 · OLAPARIB
US 8,859,562, use patent
patent.txt line 6,428- Flags
- use code U-1634
- Product numbers
- 001
4 Aug 2031 · NDA 208447 · NIRAPARIB TOSYLATE
US 8,859,562, use patent
patent.txt line 8,637- Flags
- use code U-2655
- Product numbers
- 001
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,720, 8,777- Flags
- use code U-2101
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,721, 8,778- Flags
- use code U-2103
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,722, 8,779- Flags
- use code U-2480
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,723, 8,780- Flags
- use code U-2482
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,724, 8,781- Flags
- use code U-2483
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,725, 8,782- Flags
- use code U-2716
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,726, 8,783- Flags
- use code U-2819
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,727, 8,784- Flags
- use code U-2820
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,728, 8,785- Flags
- use code U-2821
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,729, 8,786- Flags
- use code U-2822
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,730, 8,787- Flags
- use code U-2823
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,731, 8,788- Flags
- use code U-2824
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,732, 8,789- Flags
- use code U-2832
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,733, 8,790- Flags
- use code U-2833
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,734, 8,791- Flags
- use code U-3333
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,735, 8,792- Flags
- use code U-3631
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208558 · OLAPARIB
US 8,859,562, use patent
patent.txt lines 8,736, 8,793- Flags
- use code U-3695
- Product numbers
- 001, 002
4 Aug 2031 · NDA 208845 · TRIAMCINOLONE ACETONIDE
US 8,828,440, product patent
patent.txt line 9,577- Flags
- product
- Product numbers
- 001
4 Aug 2031 · NDA 208845 · TRIAMCINOLONE ACETONIDE
US 9,555,048, use patent
patent.txt line 9,578- Flags
- use code U-2151
- Product numbers
- 001
4 Aug 2031 · NDA 209115 · RUCAPARIB CAMSYLATE
US 8,859,562, use patent
patent.txt lines 9,740, 9,759, 9,778- Flags
- use code U-2012
- Product numbers
- 001, 002, 003
4 Aug 2031 · NDA 209115 · RUCAPARIB CAMSYLATE
US 8,859,562, use patent
patent.txt lines 9,741, 9,760, 9,779- Flags
- use code U-2273
- Product numbers
- 001, 002, 003
4 Aug 2031 · NDA 209115 · RUCAPARIB CAMSYLATE
US 8,859,562, use patent
patent.txt lines 9,742, 9,761, 9,780- Flags
- use code U-2830
- Product numbers
- 001, 002, 003
4 Aug 2031 · NDA 214876 · NIRAPARIB TOSYLATE
US 8,859,562, use patent
patent.txt lines 16,281, 16,290, 16,299- Flags
- use code U-2655
- Product numbers
- 001, 002, 003
4 Aug 2031 · NDA 216793 · ABIRATERONE ACETATE; NIRAPARIB TOSYLATE
US 8,859,562, use patent
patent.txt lines 18,970, 18,994- Flags
- use code U-2830
- Product numbers
- 001, 002
4 Aug 2031 · NDA 216793 · ABIRATERONE ACETATE; NIRAPARIB TOSYLATE
US 8,859,562, use patent
patent.txt lines 18,971, 18,995- Flags
- use code U-4368
- Product numbers
- 001, 002
4 Aug 2031 · NDA 217700 · TOVORAFENIB
US 8,293,752, substance and product patent
patent.txt line 20,335- Flags
- substance product
- Product numbers
- 001
4 Aug 2031 · NDA 218033 · TOVORAFENIB
US 8,293,752, substance and product patent
patent.txt line 20,785- Flags
- substance product
- Product numbers
- 001
6 Aug 2031 · NDA 214047 · LEVOTHYROXINE SODIUM
US 9,050,307, product patent
patent.txt line 15,461- Flags
- product
- Product numbers
- 001
7 Aug 2031 · NDA 205934 · DOCETAXEL
US 10,842,770, product and use patent
patent.txt lines 6,040, 6,050, 6,060- Flags
- product use code U-2998
- Product numbers
- 001, 002, 003
8 Aug 2031 · NDA 205175 · ECONAZOLE NITRATE
US 10,071,054, product patent
patent.txt line 5,270- Flags
- product
- Product numbers
- 001
8 Aug 2031 · NDA 206307 · FINAFLOXACIN
US 8,536,167, use patent
patent.txt line 6,459- Flags
- use code U-1679
- Product numbers
- 001
8 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 10,172,874, product patent
patent.txt line 10,782- Flags
- product
- Product numbers
- 001
8 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 10,183,034, use patent
patent.txt line 10,783- Flags
- use code U-2490
- Product numbers
- 001
8 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 10,561,675, use patent
patent.txt line 10,784- Flags
- use code U-2490
- Product numbers
- 001
8 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 11,007,206, use patent
patent.txt line 10,785- Flags
- use code U-3128
- Product numbers
- 001
8 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 12,171,772, substance patent
patent.txt line 10,787- Flags
- substance
- Product numbers
- 001
8 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 9,694,025, use patent
patent.txt line 10,791- Flags
- use code U-2120
- Product numbers
- 001
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,675,325, product patent
patent.txt line 3,360- Flags
- product
- Product numbers
- 003
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,702,576, use patent
patent.txt line 3,362- Flags
- use code U-1516
- Product numbers
- 003
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,702,576, use patent
patent.txt line 3,363- Flags
- use code U-3644
- Product numbers
- 003
11 Aug 2031 · NDA 202811 · LINACLOTIDE
US 10,702,576, use patent
patent.txt line 3,364- Flags
- use code U-4566
- Product numbers
- 003
11 Aug 2031 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,747,897, product and use patent
patent.txt lines 3,950, 3,960, 3,969, 3,978, 3,986- Flags
- product use code U-2724
- Product numbers
- 001, 002, 003, 004, 005
11 Aug 2031 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,747,897, product and use patent
patent.txt lines 3,951, 3,961, 3,970, 3,979, 3,987- Flags
- product use code U-2725
- Product numbers
- 001, 002, 003, 004, 005
11 Aug 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 8,609,707, product and use patent
patent.txt line 5,674- Flags
- product use code U-1971
- Product numbers
- 001
11 Aug 2031 · NDA 205580 · BENDAMUSTINE HYDROCHLORIDE
US 8,609,707, product and use patent
patent.txt line 5,675- Flags
- product use code U-1972
- Product numbers
- 001
11 Aug 2031 · NDA 208194 · BENDAMUSTINE HYDROCHLORIDE
US 8,609,707, product and use patent
patent.txt line 8,311- Flags
- product use code U-1542
- Product numbers
- 001
12 Aug 2031 · NDA 206494 · AVIBACTAM SODIUM; CEFTAZIDIME
US 8,471,025, substance patent
patent.txt line 6,578- Flags
- substance
- Product numbers
- 001
12 Aug 2031 · NDA 217906 · AVIBACTAM SODIUM; AZTREONAM
US 8,471,025, substance patent
patent.txt line 20,773- Flags
- substance
- Product numbers
- 001
21 Aug 2031 · NDA 209863 · TESTOSTERONE ENANTHATE
US 10,357,609, product patent
patent.txt lines 10,918, 10,941, 10,964- Flags
- product
- Product numbers
- 001, 002, 003
21 Aug 2031 · NDA 209863 · TESTOSTERONE ENANTHATE
US 10,905,827, product patent
patent.txt lines 10,922, 10,945, 10,968- Flags
- product
- Product numbers
- 001, 002, 003
21 Aug 2031 · NDA 209863 · TESTOSTERONE ENANTHATE
US 11,446,440, product patent
patent.txt lines 10,926, 10,949, 10,972- Flags
- product
- Product numbers
- 001, 002, 003
21 Aug 2031 · NDA 217389 · ENSIFENTRINE
US 9,062,047, substance and use patent
patent.txt line 19,908- Flags
- substance use code U-3962
- Product numbers
- 001
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,716,785, use patent
patent.txt lines 14,886, 14,907, 14,928, 14,949- Flags
- use code U-3136
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 10,716,785, use patent
patent.txt lines 14,887, 14,908, 14,929, 14,950- Flags
- use code U-3137
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,185,541, use patent
patent.txt lines 14,888, 14,909, 14,930, 14,951- Flags
- use code U-3140
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,241,425, use patent
patent.txt lines 14,889, 14,910, 14,931, 14,952- Flags
- use code U-3137
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,351,166, use patent
patent.txt lines 14,890, 14,911, 14,932, 14,953- Flags
- use code U-3140
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,351,166, use patent
patent.txt lines 14,891, 14,912, 14,933, 14,954- Flags
- use code U-3141
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 11,793,805, use patent
patent.txt lines 14,893, 14,914, 14,935, 14,956- Flags
- use code U-3734
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 12,194,035, use patent
patent.txt lines 14,896, 14,917, 14,938, 14,959- Flags
- use code U-3141
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,126,977, product and use patent
patent.txt lines 14,901, 14,922, 14,943, 14,964- Flags
- product use code U-3136
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,126,977, product and use patent
patent.txt lines 14,902, 14,923, 14,944, 14,965- Flags
- product use code U-3137
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,517,235, use patent
patent.txt lines 14,903, 14,924, 14,945, 14,966- Flags
- use code U-3138
- Product numbers
- 001, 002, 003, 004
23 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,517,235, use patent
patent.txt lines 14,904, 14,925, 14,946, 14,967- Flags
- use code U-3139
- Product numbers
- 001, 002, 003, 004
25 Aug 2031 · NDA 210598 · REVEFENACIN
US 8,541,451, substance patent
patent.txt line 12,045- Flags
- substance
- Product numbers
- 001
26 Aug 2031 · NDA 212520 · OXYMETAZOLINE HYDROCHLORIDE
US 10,912,765, use patent
patent.txt line 14,136- Flags
- use code U-2849
- Product numbers
- 001
26 Aug 2031 · NDA 212520 · OXYMETAZOLINE HYDROCHLORIDE
US 8,357,714, use patent
patent.txt line 14,145- Flags
- use code U-2849
- Product numbers
- 001
26 Aug 2031 · NDA 212520 · OXYMETAZOLINE HYDROCHLORIDE
US 9,867,808, use patent
patent.txt line 14,146- Flags
- use code U-2849
- Product numbers
- 001
26 Aug 2031 · NDA 213433 · CLASCOTERONE
US 9,433,628, substance and product patent
patent.txt line 15,011- Flags
- substance product
- Product numbers
- 001
29 Aug 2031 · NDA 209776 · MEROPENEM; VABORBACTAM
US 8,680,136, substance and product patent
patent.txt line 10,790- Flags
- substance product
- Product numbers
- 001
30 Aug 2031 · NDA 213378 · OLANZAPINE; SAMIDORPHAN L-MALATE
US 9,119,848, substance patent
patent.txt lines 14,900, 14,921, 14,942, 14,963- Flags
- substance
- Product numbers
- 001, 002, 003, 004
31 Aug 2031 · NDA 212154 · VILTOLARSEN
US 10,870,676, substance and product and use patent
patent.txt line 13,603- Flags
- substance product use code U-3039
- Product numbers
- 001
31 Aug 2031 · NDA 215559 · PALOVAROTENE
US 10,292,954, use patent
patent.txt lines 17,426, 17,435, 17,444, 17,453, 17,462- Flags
- use code U-3676
- Product numbers
- 001, 002, 003, 004, 005
31 Aug 2031 · NDA 215559 · PALOVAROTENE
US 12,023,312, use patent
patent.txt lines 17,429, 17,438, 17,447, 17,456, 17,465- Flags
- use code U-3966
- Product numbers
- 001, 002, 003, 004, 005
31 Aug 2031 · NDA 215559 · PALOVAROTENE
US 9,314,439, use patent
patent.txt lines 17,433, 17,442, 17,451, 17,460, 17,469- Flags
- use code U-3676
- Product numbers
- 001, 002, 003, 004, 005
31 Aug 2031 · NDA 215559 · PALOVAROTENE
US 9,789,074, use patent
patent.txt lines 17,434, 17,443, 17,452, 17,461, 17,470- Flags
- use code U-3676
- Product numbers
- 001, 002, 003, 004, 005
3 Sep 2031 · NDA 217424 · BERDAZIMER SODIUM
US 9,526,738, product patent
patent.txt line 19,941- Flags
- product
- Product numbers
- 001
4 Sep 2031 · NDA 208627 · TECOVIRIMAT
US 7,737,168, use patent
patent.txt line 9,014- Flags
- use code U-2346
- Product numbers
- 001
4 Sep 2031 · NDA 209299 · FOSTAMATINIB DISODIUM
US 7,449,458, substance patent
patent.txt lines 10,038, 10,052- Flags
- substance
- Product numbers
- 001, 002
4 Sep 2031 · NDA 214518 · TECOVIRIMAT
US 7,737,168, use patent
patent.txt line 15,863- Flags
- use code U-3377
- Product numbers
- 001
5 Sep 2031 · NDA 209819 · BUPRENORPHINE
US 8,975,270, product and use patent
patent.txt lines 10,845, 10,870- Flags
- product use code U-2175
- Product numbers
- 001, 002
5 Sep 2031 · NDA 209819 · BUPRENORPHINE
US 8,975,270, product and use patent
patent.txt lines 10,846, 10,871- Flags
- product use code U-2206
- Product numbers
- 001, 002
6 Sep 2031 · NDA 220295 · LINERIXIBAT
US 9,040,518, substance and product patent
patent.txt line 22,124- Flags
- substance product
- Product numbers
- 001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 10,307,375, product patent
patent.txt line 4,107- Flags
- product
- Product numbers
- 001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 10,660,858, product patent
patent.txt line 4,108- Flags
- product
- Product numbers
- 001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 8,895,064, product patent
patent.txt line 4,109- Flags
- product
- Product numbers
- 001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 9,132,093, product patent
patent.txt line 4,110- Flags
- product
- Product numbers
- 001
7 Sep 2031 · NDA 203634 · BUDESONIDE
US 9,192,581, product and use patent
patent.txt line 4,111- Flags
- product use code U-1325
- Product numbers
- 001
8 Sep 2031 · NDA 021856 · FEBUXOSTAT
US 8,372,872, use patent
patent.txt lines 743, 745- Flags
- use code U-1346
- Product numbers
- 001, 002
8 Sep 2031 · NDA 021856 · FEBUXOSTAT
US 9,107,912, use patent
patent.txt lines 744, 746- Flags
- use code U-1346
- Product numbers
- 001, 002
8 Sep 2031 · NDA 022500 · CLONIDINE
US 8,623,409, product patent
patent.txt lines 1,998, 2,000- Flags
- product
- Product numbers
- 001, 002
8 Sep 2031 · NDA 217370 · ACOLTREMON
US 10,028,920, use patent
patent.txt line 19,881- Flags
- use code U-1900
- Product numbers
- 001
8 Sep 2031 · NDA 217370 · ACOLTREMON
US 9,095,609, product and use patent
patent.txt line 19,884- Flags
- product use code U-1900
- Product numbers
- 001
8 Sep 2031 · NDA 217370 · ACOLTREMON
US 9,433,679, use patent
patent.txt line 19,885- Flags
- use code U-1900
- Product numbers
- 001
9 Sep 2031 · NDA 205718 · NETUPITANT; PALONOSETRON HYDROCHLORIDE
US 9,271,975, use patent
patent.txt line 5,821- Flags
- use code U-2293
- Product numbers
- 001
11 Sep 2031 · NDA 022450 · ACETAMINOPHEN
US 9,399,012, use patent
patent.txt line 1,914- Flags
- use code U-2261
- Product numbers
- 001
11 Sep 2031 · NDA 022450 · ACETAMINOPHEN
US 9,399,012, use patent
patent.txt line 1,915- Flags
- use code U-2262
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,155,002, use patent
patent.txt line 13,087- Flags
- use code U-2736
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,420,775, use patent
patent.txt line 13,094- Flags
- use code U-2736
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,420,775, use patent
patent.txt line 13,095- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,420,775, use patent
patent.txt line 13,096- Flags
- use code U-2853
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 11,052,093, substance and product and use patent
patent.txt line 13,099- Flags
- substance product use code U-2736
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 11,052,093, substance and product and use patent
patent.txt line 13,100- Flags
- substance product use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 11,052,093, substance and product and use patent
patent.txt line 13,101- Flags
- substance product use code U-2853
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 12,161,645, use patent
patent.txt line 13,105- Flags
- use code U-2853
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 12,168,015, substance and product patent
patent.txt line 13,110- Flags
- substance product
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 12,168,016, use patent
patent.txt line 13,111- Flags
- use code U-2736
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 12,168,016, use patent
patent.txt line 13,112- Flags
- use code U-2853
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 8,691,507, use patent
patent.txt line 13,114- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 8,765,732, use patent
patent.txt line 13,115- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 8,765,732, use patent
patent.txt line 13,116- Flags
- use code U-2853
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 8,895,245, use patent
patent.txt line 13,117- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,090,562, substance and product patent
patent.txt line 13,118- Flags
- substance product
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,175,331, use patent
patent.txt line 13,119- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,333,217, use patent
patent.txt line 13,120- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,334,527, use patent
patent.txt line 13,121- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,549,931, use patent
patent.txt line 13,124- Flags
- use code U-2736
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,549,931, use patent
patent.txt line 13,125- Flags
- use code U-2852
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,549,931, use patent
patent.txt line 13,126- Flags
- use code U-2853
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,855,275, use patent
patent.txt line 13,128- Flags
- use code U-2736
- Product numbers
- 001
12 Sep 2031 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,949,999, use patent
patent.txt line 13,132- Flags
- use code U-2851
- Product numbers
- 001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,610,321, use patent
patent.txt line 9,309- Flags
- use code U-1999
- Product numbers
- 001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,610,321, use patent
patent.txt line 9,310- Flags
- use code U-2230
- Product numbers
- 001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,919,024, use patent
patent.txt line 9,312- Flags
- use code U-1999
- Product numbers
- 001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,919,024, use patent
patent.txt line 9,313- Flags
- use code U-2230
- Product numbers
- 001
15 Sep 2031 · NDA 208745 · PLECANATIDE
US 9,925,231, product patent
patent.txt line 9,314- Flags
- product
- Product numbers
- 001
15 Sep 2031 · NDA 212888 · CABOTEGRAVIR; RILPIVIRINE
US 11,224,597, product and use patent
patent.txt lines 14,477, 14,487- Flags
- product use code U-3348
- Product numbers
- 001, 002
15 Sep 2031 · NDA 212888 · CABOTEGRAVIR; RILPIVIRINE
US 12,138,264, product and use patent
patent.txt lines 14,480, 14,490- Flags
- product use code U-3348
- Product numbers
- 001, 002
15 Sep 2031 · NDA 215499 · CABOTEGRAVIR
US 11,224,597, product patent
patent.txt line 17,409- Flags
- product
- Product numbers
- 001
15 Sep 2031 · NDA 215499 · CABOTEGRAVIR
US 12,138,264, product patent
patent.txt line 17,410- Flags
- product
- Product numbers
- 001
19 Sep 2031 · NDA 219155 · DELGOCITINIB
US 8,609,647, substance and product and use patent
patent.txt line 21,510- Flags
- substance product use code U-4237
- Product numbers
- 001
20 Sep 2031 · NDA 212028 · LEMBOREXANT
US 8,268,848, substance and product and use patent
patent.txt lines 13,439, 13,443- Flags
- substance product use code U-2791
- Product numbers
- 001, 002
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,267, 9,271, 9,275, 9,280- Flags
- substance product use code U-2135
- Product numbers
- 001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,268, 9,272, 9,276, 9,281- Flags
- substance product use code U-3242
- Product numbers
- 001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,269, 9,273, 9,277, 9,282- Flags
- substance product use code U-3265
- Product numbers
- 001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt lines 9,270, 9,274, 9,278, 9,283- Flags
- substance product use code U-3546
- Product numbers
- 001, 002, 003, 004
28 Sep 2031 · NDA 208716 · ABEMACICLIB
US 7,855,211, substance and product and use patent
patent.txt line 9,279- Flags
- substance product use code U-1981
- Product numbers
- 004
29 Sep 2031 · NDA 210923 · LUSUTROMBOPAG
US 9,427,402, product patent
patent.txt line 12,409- Flags
- product
- Product numbers
- 001
30 Sep 2031 · NDA 021338 · FENTANYL HYDROCHLORIDE
US 8,301,238, product patent
patent.txt line 548- Flags
- product
- Product numbers
- 001
30 Sep 2031 · NDA 021338 · FENTANYL HYDROCHLORIDE
US 9,364,656, use patent
patent.txt line 553- Flags
- use code U-736
- Product numbers
- 001
3 Oct 2031 · NDA 209310 · MOMETASONE FUROATE
US 10,357,640, use patent
patent.txt line 10,072- Flags
- use code U-2272
- Product numbers
- 001
10 Oct 2031 · NDA 022156 · CLEVIDIPINE
US 10,010,537, product patent
patent.txt lines 1,123, 1,126, 1,129- Flags
- product
- Product numbers
- 001, 002, 003
10 Oct 2031 · NDA 022156 · CLEVIDIPINE
US 11,103,490, product patent
patent.txt lines 1,124, 1,127, 1,130- Flags
- product
- Product numbers
- 001, 002, 003
10 Oct 2031 · NDA 022156 · CLEVIDIPINE
US 8,658,676, product patent
patent.txt lines 1,125, 1,128, 1,131- Flags
- product
- Product numbers
- 001, 002, 003
12 Oct 2031 · NDA 214511 · PEGULICIANINE ACETATE
US 9,155,471, use patent
patent.txt line 15,832- Flags
- use code U-3890
- Product numbers
- 001
14 Oct 2031 · NDA 022081 · AMBRISENTAN
US 9,549,926, use patent
patent.txt lines 1,042, 1,045- Flags
- use code U-1965
- Product numbers
- 001, 002
17 Oct 2031 · NDA 021338 · FENTANYL HYDROCHLORIDE
US 9,731,121, product patent
patent.txt line 554- Flags
- product
- Product numbers
- 001
20 Oct 2031 · NDA 208623 · MIGALASTAT HYDROCHLORIDE
US RE48608, use patent
patent.txt line 8,993- Flags
- use code U-2371
- Product numbers
- 001
20 Oct 2031 · NDA 211651 · TALAZOPARIB TOSYLATE
US 10,189,837, substance and product patent
patent.txt lines 12,932, 12,938, 12,943, 12,949, 12,954, 12,960- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
20 Oct 2031 · NDA 211651 · TALAZOPARIB TOSYLATE
US 8,735,392, substance and product patent
patent.txt lines 12,936, 12,941, 12,947, 12,952, 12,958, 12,964- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
20 Oct 2031 · NDA 217439 · TALAZOPARIB TOSYLATE
US 10,189,837, substance and product patent
patent.txt lines 19,945, 19,951, 19,957, 19,963, 19,969, 19,975- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
20 Oct 2031 · NDA 217439 · TALAZOPARIB TOSYLATE
US 8,735,392, substance and product patent
patent.txt lines 19,949, 19,955, 19,961, 19,967, 19,973, 19,979- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
21 Oct 2031 · NDA 202813 · BECLOMETHASONE DIPROPIONATE
US 10,188,811, product patent
patent.txt lines 3,377–3,378- Flags
- product
- Product numbers
- 001, 002
22 Oct 2031 · NDA 021355 · DROSPIRENONE; ESTRADIOL
US 8,906,890, product patent
patent.txt line 558- Flags
- product
- Product numbers
- 001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,189,849, substance patent
patent.txt line 15,633- Flags
- substance
- Product numbers
- 001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,189,850, product patent
patent.txt line 15,634- Flags
- product
- Product numbers
- 001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 10,927,120, product patent
patent.txt line 15,635- Flags
- product
- Product numbers
- 001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 11,040,042, product patent
patent.txt line 15,638- Flags
- product
- Product numbers
- 001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 8,598,197, substance and product patent
patent.txt line 15,645- Flags
- substance product
- Product numbers
- 001
25 Oct 2031 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 9,957,276, substance patent
patent.txt line 15,648- Flags
- substance
- Product numbers
- 001
26 Oct 2031 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 11,446,266, use patent
patent.txt line 16,775- Flags
- use code U-3744
- Product numbers
- 001
26 Oct 2031 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 11,446,266, use patent
patent.txt line 16,776- Flags
- use code U-3745
- Product numbers
- 001
26 Oct 2031 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 11,896,567, use patent
patent.txt line 16,777- Flags
- use code U-3744
- Product numbers
- 001
26 Oct 2031 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 11,896,567, use patent
patent.txt line 16,778- Flags
- use code U-3745
- Product numbers
- 001
26 Oct 2031 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 12,220,392, use patent
patent.txt line 16,781- Flags
- use code U-4306
- Product numbers
- 001
26 Oct 2031 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 12,220,392, use patent
patent.txt line 16,782- Flags
- use code U-4307
- Product numbers
- 001
27 Oct 2031 · NDA 215596 · MARIBAVIR
US 12,447,169, use patent
patent.txt line 17,475- Flags
- use code U-4329
- Product numbers
- 001
27 Oct 2031 · NDA 215596 · MARIBAVIR
US 12,661,368, use patent
patent.txt line 17,478- Flags
- use code U-4572
- Product numbers
- 001
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,748,573, use patent
patent.txt line 3,338- Flags
- use code U-4345
- Product numbers
- 001
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,748,573, use patent
patent.txt lines 3,336, 3,351- Flags
- use code U-1515
- Product numbers
- 001, 002
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,748,573, use patent
patent.txt lines 3,337, 3,352- Flags
- use code U-1516
- Product numbers
- 001, 002
30 Oct 2031 · NDA 202811 · LINACLOTIDE
US 8,802,628, product patent
patent.txt lines 3,340, 3,354- Flags
- product
- Product numbers
- 001, 002
31 Oct 2031 · NDA 202292 · CROFELEMER
US 8,962,680, use patent
patent.txt line 2,975- Flags
- use code U-1319
- Product numbers
- 001
31 Oct 2031 · NDA 202292 · CROFELEMER
US 9,585,868, use patent
patent.txt line 2,976- Flags
- use code U-1319
- Product numbers
- 001
2 Nov 2031 · NDA 207924 · BARICITINIB
US 11,806,555, use patent
patent.txt lines 7,475, 7,481, 7,487- Flags
- use code U-3500
- Product numbers
- 001, 002, 003
2 Nov 2031 · NDA 207924 · BARICITINIB
US 9,737,469, use patent
patent.txt lines 7,479, 7,485, 7,490- Flags
- use code U-3500
- Product numbers
- 001, 002, 003
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 10,478,502, product and use patent
patent.txt line 10,163- Flags
- product use code U-2625
- Product numbers
- 001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 11,839,656, use patent
patent.txt line 10,166- Flags
- use code U-2625
- Product numbers
- 001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 11,957,753, product patent
patent.txt line 10,167- Flags
- product
- Product numbers
- 001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 11,986,527, use patent
patent.txt line 10,168- Flags
- use code U-2625
- Product numbers
- 001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 12,076,403, product patent
patent.txt line 10,169- Flags
- product
- Product numbers
- 001
2 Nov 2031 · NDA 209354 · HALOBETASOL PROPIONATE; TAZAROTENE
US 8,809,307, product patent
patent.txt line 10,170- Flags
- product
- Product numbers
- 001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 10,478,502, product and use patent
patent.txt line 10,171- Flags
- product use code U-2625
- Product numbers
- 001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 11,839,656, use patent
patent.txt line 10,172- Flags
- use code U-2625
- Product numbers
- 001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 11,957,753, product patent
patent.txt line 10,173- Flags
- product
- Product numbers
- 001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 11,986,527, use patent
patent.txt line 10,174- Flags
- use code U-2625
- Product numbers
- 001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 12,076,403, product patent
patent.txt line 10,175- Flags
- product
- Product numbers
- 001
2 Nov 2031 · NDA 209355 · HALOBETASOL PROPIONATE
US 8,809,307, product patent
patent.txt line 10,176- Flags
- product
- Product numbers
- 001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,052,334, use patent
patent.txt line 13,798- Flags
- use code U-2968
- Product numbers
- 001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,195,210, use patent
patent.txt line 13,799- Flags
- use code U-2968
- Product numbers
- 001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,342,800, use patent
patent.txt line 13,800- Flags
- use code U-2968
- Product numbers
- 001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 10,722,522, use patent
patent.txt line 13,802- Flags
- use code U-2968
- Product numbers
- 001
7 Nov 2031 · NDA 212295 · REMIMAZOLAM BESYLATE
US 9,737,547, use patent
patent.txt line 13,805- Flags
- use code U-2968
- Product numbers
- 001
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,011,633, use patent
patent.txt lines 17,296, 17,324, 17,352, 17,380- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,011,633, use patent
patent.txt lines 17,297, 17,325, 17,353, 17,381- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,093,697, use patent
patent.txt lines 17,298, 17,326, 17,354, 17,382- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,093,697, use patent
patent.txt lines 17,299, 17,327, 17,355, 17,383- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,487,111, use patent
patent.txt lines 17,300, 17,328, 17,356, 17,384- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,487,111, use patent
patent.txt lines 17,301, 17,329, 17,357, 17,385- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,981,952, use patent
patent.txt lines 17,303, 17,331, 17,359, 17,387- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,981,952, use patent
patent.txt lines 17,304, 17,332, 17,360, 17,388- Flags
- use code U-3187
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,981,952, use patent
patent.txt lines 17,305, 17,333, 17,361, 17,389- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 10,981,952, use patent
patent.txt lines 17,306, 17,334, 17,362, 17,390- Flags
- use code U-3649
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 11,732,006, use patent
patent.txt lines 17,310, 17,338, 17,366, 17,394- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 11,732,006, use patent
patent.txt lines 17,311, 17,339, 17,367, 17,395- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 12,187,812, use patent
patent.txt lines 17,315, 17,343, 17,371, 17,399- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 12,187,812, use patent
patent.txt lines 17,316, 17,344, 17,372, 17,400- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 12,545,705, use patent
patent.txt lines 17,320, 17,348, 17,376, 17,404- Flags
- use code U-3186
- Product numbers
- 001, 002, 003, 004
8 Nov 2031 · NDA 215498 · ODEVIXIBAT
US 12,545,705, use patent
patent.txt lines 17,321, 17,349, 17,377, 17,405- Flags
- use code U-3648
- Product numbers
- 001, 002, 003, 004
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,193,732, substance and product patent
patent.txt line 9,711- Flags
- substance product
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,721- Flags
- use code U-1981
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,722- Flags
- use code U-2355
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,723- Flags
- use code U-2356
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,724- Flags
- use code U-3265
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,725- Flags
- use code U-3266
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,726- Flags
- use code U-3975
- Product numbers
- 001
9 Nov 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 9,727- Flags
- use code U-3999
- Product numbers
- 001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,193,732, substance and product patent
patent.txt line 11,052- Flags
- substance product
- Product numbers
- 001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 11,058- Flags
- use code U-2505
- Product numbers
- 001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 11,059- Flags
- use code U-3264
- Product numbers
- 001
9 Nov 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,868,739, use patent
patent.txt line 11,060- Flags
- use code U-3998
- Product numbers
- 001
10 Nov 2031 · NDA 211765 · UBROGEPANT
US 9,499,545, substance and product and use patent
patent.txt lines 13,169, 13,181- Flags
- substance product use code U-2718
- Product numbers
- 001, 002
10 Nov 2031 · NDA 211765 · UBROGEPANT
US 9,833,448, use patent
patent.txt lines 13,170, 13,182- Flags
- use code U-2718
- Product numbers
- 001, 002
10 Nov 2031 · NDA 215206 · ATOGEPANT
US 9,499,545, substance and product and use patent
patent.txt lines 16,565, 16,572, 16,578- Flags
- substance product use code U-3534
- Product numbers
- 001, 002, 003
11 Nov 2031 · NDA 208854 · NALDEMEDINE TOSYLATE
US 9,108,975, substance and product patent
patent.txt line 9,581- Flags
- substance product
- Product numbers
- 001
16 Nov 2031 · NDA 212327 · FEDRATINIB HYDROCHLORIDE
US 7,528,143, substance and product patent
patent.txt line 13,951- Flags
- substance product
- Product numbers
- 001
17 Nov 2031 · NDA 050808 · MINOCYCLINE HYDROCHLORIDE
US 9,192,615, product patent
patent.txt lines 2,166, 2,168- Flags
- product
- Product numbers
- 004, 005
21 Nov 2031 · NDA 208573 · VENETOCLAX
US 10,730,873, substance patent
patent.txt lines 8,860, 8,874, 8,888- Flags
- substance
- Product numbers
- 001, 002, 003
27 Nov 2031 · NDA 212888 · CABOTEGRAVIR; RILPIVIRINE
US RE50189, use patent
patent.txt lines 14,485, 14,495- Flags
- use code U-3348
- Product numbers
- 001, 002
28 Nov 2031 · NDA 215904 · GANAXOLONE
US 8,318,714, product patent
patent.txt line 18,085- Flags
- product
- Product numbers
- 001
29 Nov 2031 · NDA 218171 · ENSARTINIB HYDROCHLORIDE
US 9,126,947, substance patent
patent.txt lines 20,866, 20,870- Flags
- substance
- Product numbers
- 001, 002
1 Dec 2031 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE
US 8,883,838, product patent
patent.txt line 8,678- Flags
- product
- Product numbers
- 001
5 Dec 2031 · NDA 202344 · ALENDRONATE SODIUM
US 9,592,195, product patent
patent.txt line 3,083- Flags
- product
- Product numbers
- 001
5 Dec 2031 · NDA 209637 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt lines 10,691, 10,709- Flags
- substance product use code U-2202
- Product numbers
- 001, 002
5 Dec 2031 · NDA 209637 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt lines 10,726, 10,761, 10,768, 10,777- Flags
- substance product use code U-3355
- Product numbers
- 003, 005, 006, 007
5 Dec 2031 · NDA 209637 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt line 10,744- Flags
- substance product use code U-3469
- Product numbers
- 004
5 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 8,129,343, substance and product and use patent
patent.txt lines 14,591, 14,606, 14,621, 14,631, 14,640, 14,649- Flags
- substance product use code U-2628
- Product numbers
- 001, 002, 003, 004, 005, 006
5 Dec 2031 · NDA 215256 · SEMAGLUTIDE
US 8,129,343, substance and product patent
patent.txt lines 16,608, 16,616, 16,624, 16,632, 16,642, 16,651, 16,663, 16,675, 16,687, 16,699, 16,711, 16,716- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006, 007, 008, 009, 010, 011, 012
5 Dec 2031 · NDA 218316 · SEMAGLUTIDE
US 8,129,343, substance and product patent
patent.txt lines 20,939, 20,947, 20,955, 20,964- Flags
- substance product
- Product numbers
- 001, 002, 003, 004
8 Dec 2031 · NDA 214511 · PEGULICIANINE ACETATE
US 10,285,759, use patent
patent.txt line 15,829- Flags
- use code U-3890
- Product numbers
- 001
8 Dec 2031 · NDA 214511 · PEGULICIANINE ACETATE
US 9,032,965, use patent
patent.txt line 15,831- Flags
- use code U-3890
- Product numbers
- 001
8 Dec 2031 · NDA 214511 · PEGULICIANINE ACETATE
US 9,532,835, use patent
patent.txt line 15,833- Flags
- use code U-3890
- Product numbers
- 001
8 Dec 2031 · NDA 214787 · REMDESIVIR
US 11,492,353, substance patent
patent.txt lines 16,141, 16,175- Flags
- substance
- Product numbers
- 001, 002
15 Dec 2031 · NDA 207202 · ARIPIPRAZOLE
US 9,320,455, product patent
patent.txt lines 7,085, 7,112, 7,139, 7,166, 7,193, 7,220- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006
16 Dec 2031 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 11,419,769, product and use patent
patent.txt lines 12,318, 12,330, 12,342, 12,354, 12,366- Flags
- product use code U-2825
- Product numbers
- 001, 002, 003, 004, 005
16 Dec 2031 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 8,414,922, product and use patent
patent.txt lines 12,319, 12,331, 12,343, 12,355, 12,367- Flags
- product use code U-2825
- Product numbers
- 001, 002, 003, 004, 005
16 Dec 2031 · NDA 210875 · APOMORPHINE HYDROCHLORIDE
US 8,846,074, product and use patent
patent.txt lines 12,320, 12,332, 12,344, 12,356, 12,368- Flags
- product use code U-2825
- Product numbers
- 001, 002, 003, 004, 005
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 10,086,047, product patent
patent.txt lines 14,579, 14,594, 14,609- Flags
- product
- Product numbers
- 001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 10,960,052, product patent
patent.txt lines 14,582, 14,597, 14,612- Flags
- product
- Product numbers
- 001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 11,382,957, product patent
patent.txt lines 14,584, 14,599, 14,614- Flags
- product
- Product numbers
- 001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 11,382,957, substance and product patent
patent.txt lines 14,626, 14,635, 14,644- Flags
- substance product
- Product numbers
- 004, 005, 006
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 9,278,123, product and use patent
patent.txt lines 14,593, 14,608, 14,623- Flags
- product use code U-2628
- Product numbers
- 001, 002, 003
16 Dec 2031 · NDA 213051 · SEMAGLUTIDE
US 9,278,123, substance and product and use patent
patent.txt line 14,651- Flags
- substance product use code U-2628
- Product numbers
- 006
16 Dec 2031 · NDA 218316 · SEMAGLUTIDE
US 11,382,957, product patent
patent.txt lines 20,935, 20,943, 20,951, 20,960- Flags
- product
- Product numbers
- 001, 002, 003, 004
16 Dec 2031 · NDA 218316 · SEMAGLUTIDE
US 9,278,123, product and use patent
patent.txt lines 20,957, 20,966- Flags
- product use code U-4389
- Product numbers
- 003, 004
19 Dec 2031 · NDA 209803 · ERTUGLIFLOZIN
US 8,080,580, substance and product and use patent
patent.txt lines 10,800–10,801- Flags
- substance product use code U-2214
- Product numbers
- 001, 002
19 Dec 2031 · NDA 209805 · ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US 8,080,580, substance and product and use patent
patent.txt lines 10,804, 10,809- Flags
- substance product use code U-2214
- Product numbers
- 001, 002
19 Dec 2031 · NDA 209806 · ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 8,080,580, substance and product and use patent
patent.txt lines 10,812, 10,815, 10,818, 10,821- Flags
- substance product use code U-2214
- Product numbers
- 001, 002, 003, 004
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 8,808,740, product and use patent
patent.txt lines 6,617, 6,636, 6,655, 6,674, 6,693, 6,712, 6,731- Flags
- product use code U-1556
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,572,779, product patent
patent.txt lines 6,627, 6,646, 6,665, 6,684, 6,703, 6,722, 6,741- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,750,703, product patent
patent.txt lines 6,628, 6,647, 6,666, 6,685, 6,704, 6,723, 6,742- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,861,584, product patent
patent.txt lines 6,632, 6,651, 6,670, 6,689, 6,708, 6,727, 6,746- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
21 Dec 2031 · NDA 206627 · HYDROCODONE BITARTRATE
US 9,872,837, product patent
patent.txt lines 6,633, 6,652, 6,671, 6,690, 6,709, 6,728, 6,747- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
24 Dec 2031 · NDA 201444 · SODIUM NITRITE; SODIUM THIOSULFATE
US 8,568,793, substance and product patent
patent.txt line 2,434- Flags
- substance product
- Product numbers
- 001
24 Dec 2031 · NDA 203922 · SODIUM NITRITE
US 8,568,793, substance and product patent
patent.txt line 4,178- Flags
- substance product
- Product numbers
- 001
28 Dec 2031 · NDA 022192 · ILOPERIDONE
US 9,074,254, use patent
patent.txt lines 1,153, 1,167, 1,181, 1,195, 1,209, 1,223, 1,237- Flags
- use code U-1674
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
28 Dec 2031 · NDA 207988 · LESINURAD
US 9,956,205, use patent
patent.txt line 7,931- Flags
- use code U-2311
- Product numbers
- 001
28 Dec 2031 · NDA 209203 · ALLOPURINOL; LESINURAD
US 9,956,205, use patent
patent.txt lines 9,866, 9,874- Flags
- use code U-2104
- Product numbers
- 001, 002
28 Dec 2031 · NDA 220358 · MILSAPERIDONE
US 9,074,254, use patent
patent.txt lines 22,150, 22,170, 22,190, 22,210, 22,230, 22,250, 22,270- Flags
- use code U-4436
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
28 Dec 2031 · NDA 220358 · MILSAPERIDONE
US 9,074,254, use patent
patent.txt lines 22,151, 22,171, 22,191, 22,211, 22,231, 22,251, 22,271- Flags
- use code U-4437
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
Pediatric exclusivity, as listed (48)
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,291,904 with pediatric exclusivity, as listed
patent.txt lines 198, 220- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,573,209 with pediatric exclusivity, as listed
patent.txt lines 204, 226- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,573,210 with pediatric exclusivity, as listed
patent.txt lines 206, 228- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,776,794 with pediatric exclusivity, as listed
patent.txt lines 208, 230- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 8,776,795 with pediatric exclusivity, as listed
patent.txt lines 210, 232- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 9,265,911 with pediatric exclusivity, as listed
patent.txt line 238- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 9,295,802 with pediatric exclusivity, as listed
patent.txt line 242- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 003
6 Jul 2031 · NDA 020845 · NITRIC OXIDE
US 9,408,993 with pediatric exclusivity, as listed
patent.txt line 244- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 003
20 Jul 2031 · NDA 022512 · DABIGATRAN ETEXILATE MESYLATE
US 9,034,822 with pediatric exclusivity, as listed
patent.txt lines 2,015, 2,019, 2,023- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
14 Aug 2031 · NDA 208798 · FLUTICASONE PROPIONATE
US 10,195,375 with pediatric exclusivity, as listed
patent.txt lines 9,463, 9,467, 9,471, 9,475, 9,485, 9,495, 9,505, 9,509- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004, 005, 006, 007, 008
14 Aug 2031 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US 10,195,375 with pediatric exclusivity, as listed
patent.txt lines 9,519, 9,527, 9,533, 9,539, 9,553, 9,565- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004, 005, 006
17 Aug 2031 · NDA 202811 · LINACLOTIDE
US 8,933,030 with pediatric exclusivity, as listed
patent.txt lines 3,341, 3,355, 3,369- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
24 Aug 2031 · NDA 202155 · APIXABAN
US 9,326,945 with pediatric exclusivity, as listed
patent.txt lines 2,787, 2,795, 2,799- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
5 Sep 2031 · NDA 201280 · LINAGLIPTIN
US 8,853,156 with pediatric exclusivity, as listed
patent.txt line 2,338- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
13 Sep 2031 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,415,355 with pediatric exclusivity, as listed
patent.txt line 9,698- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
13 Sep 2031 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,415,355 with pediatric exclusivity, as listed
patent.txt line 11,043- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
3 Oct 2031 · NDA 208082 · DEUTETRABENAZINE
US 8,524,733 with pediatric exclusivity, as listed
patent.txt lines 8,132, 8,164, 8,196- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
3 Oct 2031 · NDA 216354 · DEUTETRABENAZINE
US 8,524,733 with pediatric exclusivity, as listed
patent.txt lines 18,549, 18,579, 18,609, 18,639, 18,669, 18,699, 18,729, 18,759- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004, 005, 006, 007, 008
10 Oct 2031 · NDA 207931 · OMBITASVIR; PARITAPREVIR; RITONAVIR
US 8,420,596 with pediatric exclusivity, as listed
patent.txt line 7,648- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
20 Nov 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,758,543 with pediatric exclusivity, as listed
patent.txt line 16,737- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
20 Nov 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 10,869,870 with pediatric exclusivity, as listed
patent.txt line 16,739- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
20 Nov 2031 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,219,624 with pediatric exclusivity, as listed
patent.txt line 16,742- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
23 Nov 2031 · NDA 200603 · LURASIDONE HYDROCHLORIDE
US 9,259,423 with pediatric exclusivity, as listed
patent.txt lines 2,249, 2,260, 2,271, 2,282, 2,293- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004, 005
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,004,746 with pediatric exclusivity, as listed
patent.txt lines 5,467, 5,566- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,016,435 with pediatric exclusivity, as listed
patent.txt lines 5,472, 5,571- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,478,439 with pediatric exclusivity, as listed
patent.txt lines 5,484, 5,583- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 10,751,342 with pediatric exclusivity, as listed
patent.txt lines 5,494, 5,593- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 8,999,999 with pediatric exclusivity, as listed
patent.txt lines 5,540, 5,637- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 9,125,889 with pediatric exclusivity, as listed
patent.txt lines 5,543, 5,641- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 9,801,881 with pediatric exclusivity, as listed
patent.txt lines 5,562, 5,659- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 205552 · IBRUTINIB
US 9,801,883 with pediatric exclusivity, as listed
patent.txt lines 5,564, 5,661- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,004,746 with pediatric exclusivity, as listed
patent.txt lines 11,587, 11,693, 11,797, 11,901- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,016,435 with pediatric exclusivity, as listed
patent.txt lines 11,594, 11,700, 11,804, 11,908- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,478,439 with pediatric exclusivity, as listed
patent.txt lines 11,604, 11,710, 11,814, 11,918- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,653,696 with pediatric exclusivity, as listed
patent.txt line 11,927- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 10,751,342 with pediatric exclusivity, as listed
patent.txt lines 11,614, 11,720, 11,824, 11,931- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 8,754,090 with pediatric exclusivity, as listed
patent.txt line 11,971- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 8,999,999 with pediatric exclusivity, as listed
patent.txt lines 11,668, 11,772, 11,876, 11,985- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,125,889 with pediatric exclusivity, as listed
patent.txt lines 11,673, 11,777, 11,881, 11,990- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,801,881 with pediatric exclusivity, as listed
patent.txt lines 11,687, 11,791, 11,895, 12,003- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,801,883 with pediatric exclusivity, as listed
patent.txt lines 11,690, 11,794, 11,898, 12,006- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
3 Dec 2031 · NDA 210563 · IBRUTINIB
US 9,814,721 with pediatric exclusivity, as listed
patent.txt line 12,009- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 004
3 Dec 2031 · NDA 217003 · IBRUTINIB
US 10,478,439 with pediatric exclusivity, as listed
patent.txt line 19,157- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
7 Dec 2031 · NDA 021035 · LEVETIRACETAM
US 8,802,142 with pediatric exclusivity, as listed
patent.txt lines 399, 401, 403, 405- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
10 Dec 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 10,130,640 with pediatric exclusivity, as listed
patent.txt line 7,364- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
10 Dec 2031 · NDA 207589 · BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
US 9,119,781 with pediatric exclusivity, as listed
patent.txt line 7,371- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
21 Dec 2031 · NDA 204026 · POMALIDOMIDE
US 8,828,427 with pediatric exclusivity, as listed
patent.txt lines 4,198, 4,204, 4,210, 4,216- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
30 Dec 2031 · NDA 204447 · VORTIOXETINE HYDROBROMIDE
US 8,722,684 with pediatric exclusivity, as listed
patent.txt lines 4,700, 4,720, 4,740, 4,760- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
Non-patent exclusivity (44)
14 Jul 2031 · NDA 219908 · GEDATOLISIB
NCE exclusivity
exclusivity.txt line 2,354- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
15 Jul 2031 · NDA 220848 · ENLICITIDE DECANOATE
NCE exclusivity
exclusivity.txt line 2,407- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
22 Jul 2031 · NDA 220185 · ZIDESAMTINIB
NCE exclusivity
exclusivity.txt lines 2,379–2,380- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001, 002
24 Jul 2031 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE-490 exclusivity
exclusivity.txt line 1,357- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 002
6 Aug 2031 · NDA 218784 · VORASIDENIB
ODE-491 exclusivity
exclusivity.txt lines 2,192, 2,194- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
9 Aug 2031 · NDA 216490 · PALOPEGTERIPARATIDE
ODE-492 exclusivity
exclusivity.txt lines 1,762, 1,764, 1,766- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003
13 Aug 2031 · NDA 220496 · FLORQUINITAU F-18
NCE exclusivity
exclusivity.txt line 2,394- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
13 Aug 2031 · NDA 221075 · IBERDOMIDE HYDROCHLORIDE
NCE exclusivity
exclusivity.txt lines 2,416–2,417- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001, 002
14 Aug 2031 · NDA 212862 · PRETOMANID
GAIN exclusivity
exclusivity.txt line 1,124- Definition
- Generating Antibiotic Incentives Now (to be checked against FDA's list)
- Product numbers
- 001
14 Aug 2031 · NDA 217899 · SELADELPAR LYSINE
ODE-486 exclusivity
exclusivity.txt line 2,024- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
26 Aug 2031 · NDA 220910 · DARAXONRASIB
NCE exclusivity
exclusivity.txt lines 2,408–2,409- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001, 002
27 Aug 2031 · NDA 220106 · BREPOCITINIB TOSYLATE
NCE exclusivity
exclusivity.txt line 2,375- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
27 Aug 2031 · NDA 220482 · CIPEPOFOL
NCE exclusivity
exclusivity.txt line 2,393- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
28 Aug 2031 · NDA 220605 · RUSFERTIDE ACETATE
NCE exclusivity
exclusivity.txt lines 2,395–2,399- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004, 005
30 Aug 2031 · NDA 209939 · LETERMOVIR
ODE-495 exclusivity
exclusivity.txt lines 822, 828- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
30 Aug 2031 · NDA 209939 · LETERMOVIR
ODE-497 exclusivity
exclusivity.txt lines 823, 829- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
30 Aug 2031 · NDA 209940 · LETERMOVIR
ODE-495 exclusivity
exclusivity.txt lines 834, 840- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
30 Aug 2031 · NDA 209940 · LETERMOVIR
ODE-497 exclusivity
exclusivity.txt lines 835, 841- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
30 Aug 2031 · NDA 219104 · LETERMOVIR
ODE-495 exclusivity
exclusivity.txt lines 2,247, 2,251- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
30 Aug 2031 · NDA 219104 · LETERMOVIR
ODE-497 exclusivity
exclusivity.txt lines 2,248, 2,252- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
4 Sep 2031 · NDA 220359 · CAMIZESTRANT
NCE exclusivity
exclusivity.txt line 2,391- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
5 Sep 2031 · NDA 216403 · SPARSENTAN
ODE-493 exclusivity
exclusivity.txt lines 1,756, 1,760- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
11 Sep 2031 · NDA 218592 · FLORETYROSINE F-18
NCE exclusivity
exclusivity.txt line 2,171- Definition
- New chemical entity (to be checked against FDA's list)
- Product numbers
- 001
20 Sep 2031 · NDA 214927 · ARIMOCLOMOL CITRATE
ODE-496 exclusivity
exclusivity.txt lines 1,417, 1,419, 1,421, 1,423- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
22 Sep 2031 · NDA 218490 · MACITENTAN; TADALAFIL
PED exclusivity
exclusivity.txt lines 2,159, 2,163- Definition
- Pediatric exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
24 Sep 2031 · NDA 219132 · LEVACETYLLEUCINE
ODE-498 exclusivity
exclusivity.txt line 2,254- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
16 Oct 2031 · NDA 214755 · SODIUM OXYBATE
ODE-494 exclusivity
exclusivity.txt lines 1,372, 1,375, 1,378, 1,381- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
23 Oct 2031 · NDA 208700 · LUTETIUM LU-177 DOTATATE
PED exclusivity
exclusivity.txt line 750- Definition
- Pediatric exclusivity (to be checked against FDA's list)
- Product numbers
- 001
29 Oct 2031 · NDA 215358 · ASCIMINIB HYDROCHLORIDE
ODE-499 exclusivity
exclusivity.txt lines 1,541, 1,549- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
29 Oct 2031 · NDA 215358 · ASCIMINIB HYDROCHLORIDE
ODE-500 exclusivity
exclusivity.txt lines 1,542, 1,550- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
15 Nov 2031 · NDA 218944 · REVUMENIB CITRATE
ODE-502 exclusivity
exclusivity.txt lines 2,214, 2,218, 2,222- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003
15 Nov 2031 · NDA 218944 · REVUMENIB CITRATE
ODE-504 exclusivity
exclusivity.txt lines 2,215, 2,219, 2,223- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003
15 Nov 2031 · NDA 218944 · REVUMENIB CITRATE
ODE-505 exclusivity
exclusivity.txt lines 2,216, 2,220, 2,224- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003
22 Nov 2031 · NDA 216540 · ACORAMIDIS HYDROCHLORIDE
ODE-506 exclusivity
exclusivity.txt line 1,768- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
29 Nov 2031 · NDA 213246 · SELPERCATINIB
PED exclusivity
exclusivity.txt lines 1,185–1,187, 1,207–1,209- Definition
- Pediatric exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
29 Nov 2031 · NDA 218160 · SELPERCATINIB
PED exclusivity
exclusivity.txt lines 2,053–2,055, 2,073–2,075, 2,093–2,095, 2,113–2,115- Definition
- Pediatric exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003, 004
13 Dec 2031 · NDA 218808 · CRINECERFONT
ODE-503 exclusivity
exclusivity.txt lines 2,203, 2,205, 2,207- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002, 003
13 Dec 2031 · NDA 218820 · CRINECERFONT
ODE-503 exclusivity
exclusivity.txt line 2,209- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
19 Dec 2031 · NDA 218614 · OLEZARSEN SODIUM
ODE-515 exclusivity
exclusivity.txt line 2,173- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
20 Dec 2031 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
ODE-512 exclusivity
exclusivity.txt lines 1,038, 1,044- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
20 Dec 2031 · NDA 213793 · SETMELANOTIDE ACETATE
ODE-508 exclusivity
exclusivity.txt line 1,268- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
20 Dec 2031 · NDA 213793 · SETMELANOTIDE ACETATE
ODE-509 exclusivity
exclusivity.txt line 1,269- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
20 Dec 2031 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
ODE-512 exclusivity
exclusivity.txt lines 1,903, 1,907- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
20 Dec 2031 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
ODE-526 exclusivity
exclusivity.txt lines 2,180, 2,183- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002